Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Carcinoma, Non-Small-Cell Lung 2 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Fallopian Tube Neoplasms 1 Carcinoma 1

Interventions

Cisplatin 12 pembrolizumab 11 Magnetic Resonance Spectroscopy 11 Specimen Handling 10 Paclitaxel 6 Platinum 5 Cyclophosphamide 5 1,2-diaminocyclohexaneplatinum II citrate 5 fludarabine 4 durvalumab 4 cemiplimab 4 Radiotherapy, Intensity-Modulated 4 Radiotherapy 3 Pemetrexed 3 Oxaliplatin 3 Nivolumab 3 Fluorouracil 3 Cetuximab 3 Carboplatin 3 Biopsy 3 poly ICLC 2 fludarabine phosphate 2 cabozantinib 2 atezolizumab 2 Radiation 2 Ipilimumab 2 Interviews as Topic 2 Heavy Ion Radiotherapy 2 Gemcitabine 2 Drug Therapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Carcinoma × Maintenance × Clear all

NCT06827353 2025-02-14

OVNI-B

Centre Hospitalier Universitaire de Nīmes

Carcinoma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡